Drug Trial Radar · NCT07482176
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Last checked: Nov 20, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
534
Planned (sponsor's estimate)
Start
Mar 16, 2026
Primary completion
Nov 15, 2027
Study completion Oct 20, 2031
Sponsor
- Lead sponsor
- Adverum Biotechnologies, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 19, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, randomized, double-masked, active-comparator-controlled, Phase 3 study in a broad participant population (treatment-naïve and treatment-experienced) with neovascular (wet) age-related macular degeneration (nAMD). The study will evaluate a single intravitreal (IVT) injection of Ixo-vec compared to intravitreal aflibercept (active comparator). The primary endpoint of this study is the mean change in best corrected visual acuity (BCVA) of Ixo-vec compared to an active comparator measured as an average at Weeks 52 and 56. Safety, tolerability, and efficacy will be evaluated throughout the study.
Conditions
- Neovascular Age-Related Macular Degeneration (nAMD)
- Wet AMD
Interventions
Ixo-vecGenetic
Ixo-vec will be administered intravitreally.
AfliberceptDrug
Aflibercept will be administered intravitreally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change from Baseline in BCVA Based on an Average at Weeks 52 and 56Time frame: Baseline, Week 52 and Week 56
Locations
79 sites in 1 country. Site status is shown where the registry gives one.
Adverum Clinical Site 245
Mesa, Arizona · Recruiting
Adverum Clinical Site 126
Phoenix, Arizona · Recruiting
Adverum Clinical Site 178
Phoenix, Arizona · Recruiting
Adverum Clinical Site 223
Phoenix, Arizona · Recruiting
Adverum Clinical Site 229
Scottsdale, Arizona · Recruiting
Adverum Clinical Site 242
Sun City, Arizona · Recruiting
Adverum Clinical Site 198
Springdale, Arkansas · Recruiting
Adverum Clinical Site 109
Bakersfield, California · Recruiting
Adverum Clinical Site 100
Beverly Hills, California · Recruiting
Adverum Clinical Site 201
Campbell, California · Recruiting
Adverum Clinical Site 172
Encino, California · Recruiting
Adverum Clinical Site 169
Fullerton, California · Recruiting
Adverum Clinical Site 224
Huntington Beach, California · Recruiting
Adverum Clinical Site 130
Poway, California · Recruiting
Adverum Clinical Site 215
Redlands, California · Recruiting
Adverum Clinical Site 140
Sacramento, California · Recruiting
Adverum Clinical Site 212
Sacramento, California · Recruiting
Adverum Clinical Site 175
Santa Barbara, California · Recruiting
Adverum Clinical Site 202
Torrance, California · Recruiting
Adverum Clinical Site 189
Walnut Creek, California · Recruiting
Adverum Clinical Site 200
Denver, Colorado · Recruiting
Adverum Clinical Site 116
Denver, Colorado · Recruiting
Adverum Clinical Site 165
Waterford, Connecticut · Recruiting
Adverum Clinical Site 124
Deerfield Beach, Florida · Recruiting
Adverum Clinical Site 184
Deerfield Beach, Florida · Recruiting
Adverum Clinical Site 176
Fort Lauderdale, Florida · Recruiting
Adverum Clinical Site 221
Fort Myers, Florida · Recruiting
Adverum Clinical Site 236
Gainesville, Florida · Recruiting
Adverum Clinical Site 214
Lakeland, Florida · Recruiting
Adverum Clinical Site 168
Miami Springs, Florida · Recruiting
Adverum Clinical Site 213
Orlando, Florida · Recruiting
Adverum Clinical Site 206
Plantation, Florida · Recruiting
Adverum Clinical Site 183
South Miami, Florida · Recruiting
Adverum Clinical Site 120
St. Petersburg, Florida · Recruiting
Adverum Clinical Site 148
Tampa, Florida · Recruiting
Adverum Clinical Site 238
Winter Haven, Florida · Recruiting
Adverum Clinical Site 182
Augusta, Georgia · Recruiting
Adverum Clinical Site 246
Chicago, Illinois · Recruiting
Adverum Clinical Site 179
Oak Forest, Illinois · Recruiting
Adverum Clinical Site 207
Oak Park, Illinois · Recruiting
Showing 40 of 79 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.